Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation

Transplantation

Volumn 86, Issue 11, 2008, Pages 1578-1585

  Bockhorn, Maximilian ^a   Fingas, Christian D ^a   Rauen, Ursula ^a   Canbay, Ali ^a   Sotiropoulos, Georgios C ^a   Frey, Ulrich ^a   Sheu, Shin Yi ^a   Wohlschläger, Jeremias ^a   Broelsch, Christoph E ^a   Schlaak, Jörg F ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Animal models; Apoptosis; Gene expression; Liver regeneration; Living donor liver transplantation; Surgery

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMATE DEHYDROGENASE; INTERLEUKIN 6; KI 67 ANTIGEN; PROTEIN BCL XL; PROTEIN C JUN; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CELL; LIVER FUNCTION TEST; LIVER INJURY; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; MALE; NICK END LABELING; NONHUMAN; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANIMAL MODEL; CYTOLOGY; DNA MICROARRAY; LEWIS RAT; LIVER; LIVER RESECTION; METHODOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANIMALS; CELL PROLIFERATION; ERYTHROPOIETIN, RECOMBINANT; HEPATECTOMY; HEPATOCYTES; LIVER; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 58149342075     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818b22b4     Document Type: Article

References (41)

1. Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 1991; 214: 428.
2. Lo CM, Fan ST, Liu CL, et al. Minimum graft size for successful living donor liver transplantation. Transplantation 1999; 68: 1112.
3. Valentin-Gamazo C, Malago M, Karliova M, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004; 10: 1087.
4. Bockhorn M, Frilling A, Benko T, et al. Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy. Eur Surg Res 2007; 39: 58.
5. Bockhorn M, Goralski M, Prokofiev D, et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007; 138: 291.
6. Erslev AJ. Erythropoietin. N Engl J Med 1991; 324: 1339.
7. Krantz SB. Erythropoietin. Blood 1991; 77: 419.
8. Jaquet K, Krause K, Tawakol-Khodai M, et al. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002; 64: 326.
9. Ribatti D, Vacca A, Roccaro AM, et al. Erythropoietin as an angiogenic factor. Eur J Clin Invest 2003; 33: 891.
10. Tan CC, Eckardt KU, Ratcliffe PJ. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 1991; 40: 69.
11. Naughton BA, Kaplan SM, Roy M, et al. Hepatic regeneration and erythropoietin production in the rat. Science 1977; 196: 301.
12. Dornfest BS, Naughton BA, Kolks GA, et al. Recovery of an erythro-poietin inducing factor from the regenerating rat liver. Ann Clin Lab Sci 1981; 11: 37.
13. Gordon AS, Naughton BA. Mechanisms of extrarenal erythropoietin (Ep) production. Exp Hematol 1980; 8(suppl 8): 14.
14. Naughton BA, Birnbach DJ, Liu P, et al. Reticuloendothelial system (RES) hyperfunction and erythropoietin (Ep) production in the regenerating liver. J Surg Oncol 1979; 12: 227.
15. Naughton GK, Naughton BA, Gordon AS. Erythropoietin production by macrophages in the regenerating liver. J Surg Oncol 1985; 30: 184.
16. Paul P, Rothmann SA, McMahon JT, et al. Erythropoietin secretion by isolated rat Kupffer cells. Exp Hematol 1984; 12: 825.
17. Naughton BA, Kolks GA, Arce JM, etal. The regenerating liver: A site of erythropoiesis in the adult Long-Evans rat. Am J Anat 1979; 156: 159.
18. Emond J, Capron-Laudereau M, Meriggi F, et al. Extent of hepatec-tomy in the rat. Evaluation of basal conditions and effect of therapy. Eur Surg Res 1989; 21: 251.
19. Higgins GM, Andersson T. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186.
20. Kamada N, Calne RY. Orthotopic liver transplantation inthe rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
21. Schlaak JF, Hilkens CM, Costa-Pereira AP, et al. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem 2002; 277: 49428.
22. MalikR,Habib M,Tootle R, etal. Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential - A study relevant to donor preconditioning. Am J Transplant 2005; 5: 1801.
23. Sepodes B, Maio R, Pinto R, et al. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl Int 2006; 19: 919.
24. Malik R, Mellor N, Selden C, et al. Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 2003; 37: 79.
25. Jacobs-Helber SM, Wickrema A, Birrer MJ, et al. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol Cell Biol 1998; 18: 3699.
26. Seong SR, Lee JW, Lee YK, et al. Stimulation of cell growth by erythro-poietin in RAW264.7 cells: Association with AP-1 activation. Arch Pharm Res 2006; 29: 218.
27. Behrens A, Sibilia M, David JP, et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2002; 21: 1782.
28. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45.
29. Bakiri L, LallemandD, Bossy-Wetzel E, etal. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. EMBO J 2000; 19: 2056.
30. Liu YC, Chang HW, Lai YC, et al. Serum responsiveness of the rat PCNA promoter involves the proximal ATF and AP-1 sites. FEBS Lett 1998; 441: 200.
31. Shaulian E, Schreiber M, Piu F, et al. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000; 103: 897.
32. Wisdom R, Johnson RS, Moore C.c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 1999; 18: 188.
33. Hilberg F, Aguzzi A, Howells N, et al. c-jun is essential for normal mouse development and hepatogenesis. Nature 1993; 365: 179.
34. Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003; 100: 4802.
35. Brines M, Grasso G, Fiordaliso F, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004; 101: 14907.
36. Celik M, Gokmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258.
37. Abdelrahman M, Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004; 22: 63.
38. Eferl R, Ricci R, Kenner L, et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 2003; 112: 181.
39. Eferl R, Sibilia M, Hilberg F, et al. Functions of c-Jun in liver and heart development. J Cell Biol 1999; 145: 1049.
40. l in rats. World J Gastroenterol 2005; 11: 2579.
41. Gewirtz DA, Di X, Walker TD, et al. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Clin Cancer Res 2006; 12: 2232.